http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2009542383-A
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-12 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-42 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-32 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-45 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L27-222 |
| classificationIPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-12 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61F2-44 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61F2-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L27-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P19-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P19-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P19-08 |
| filingDate | 2007-07-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2009-12-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | JP-2009542383-A |
| titleOfInvention | Use of gelatin and a cross-linking agent to produce a cross-linking therapeutic composition |
| abstract | The object of the present invention is a therapeutic composition for use in a biological regeneration method, which ensures that suspended cells and / or growth factors remain in the target area of the body and at the same time an unreasonable period It is to provide a composition that can be administered to a target area of the body while eliminating the need for the patient to hold a fixed treatment body area between. To this end, the present invention relates to a novel use of gelatin and a cross-linking agent to produce a cross-linked therapeutic composition that forms a cross-linked gelatin gel as a cellular matrix in a target area of the human or animal body. In particular, the invention relates to the use of the above therapeutic compositions for treating damage to intervertebral discs, cartilage, meniscus, tendons or bones in humans or animals. According to the above method, (i) gelatin and crosslinking agent are mixed together to form a crosslinked therapeutic composition, which is then administered to the target area; or (ii) gelatin and crosslinking agent are in separate forms And are administered simultaneously or sequentially to the target area while forming a cross-linked therapeutic composition. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2016052314-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2009542384-A |
| priorityDate | 2006-07-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 118.